LeafNLP Demos
Back to explore

Report #2890617

Received Mar 24, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
PA
Recovered
Unknown
Vaccinated
Dec 19, 2025
Onset
Dec 26, 2025
Days to onset
7
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
MMRMEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.UNKZ003401—
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.UNKY017914—

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

No additional AE reported; Physician assistant reported that a patient received MMR II on 12/19/2025 and VARIVAX on 12/26/2025. No additional AE/No PQC reported.; This spontaneous report was received from an Other health professional (physical assistant) and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 19-Dec-2025, the patient was vaccinated with 1 dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), lot #Z003401, expiration date: 23-Jan-2027 (exact dose, route of administration and anatomical location were not provided) for prophylaxis. The vaccine was reconstituted with 1 dose of sterile diluent (Hollister-Stier STERILE DILUENT) (lot # and expiration date were not reported). On 26-Dec-2025, the patient was vaccinated with 1 dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), lot #Y017914, expiration date: 28-Oct-2026) (exact dose, route of administration and anatomical location were not provided) for prophylaxis (inappropriate schedule of product administration). No additional adverse event reported (no adverse event).

Other medications

DILUENT MRK